Chennai, Oct 13. Using the patient’s own immune cells, Cancer can be tackled for better outcome as presented by leading experts from Japan and Indian counterparts in the one-day international meeting - the seventh anniversary of Nichi-In Centre for Regenerative Medicine- NCRM NICHE 2012. Prof. Iwasaki of Yamanashi University and Dr Terunuma from Japan presented the immune cell based therapies in clinical practice in Japan that have helped improve the survival of Cancer patients and similar encouraging outcome from India were presented by Dr Deenadayalan of Apollo Hospitals, Chennai, Dr Sumana Premkumar of Kamakshi Memorial Hospital, Chennai and Dr Ramanan of MCCF, Chennai.
One among every three person in Japan is becoming a victim to cancer in his/her lifetime according to Dr Iwasaki and Dr Terunuma. Japanese hospitals since late 80s have been practicing autologous cell based immune therapies in which, the cancer patient’s own peripheral blood derived Natural Killer cells and Cancer-killing lymphocytes are multiplied in the laboratory and given intravenously to treat cancer. This treatment named as Autologous Immune Enhancement Therapy (AIET; www.immunotreatment.org) can be administered at any stage of Cancer as it has almost no side effects. AIET when combined with conventional treatments, the survival is improved by 35% or more. Their Indian counterparts shared their experience in India where a Philadelphia Chromosome positive Acute Lymphoblastic Leukemia patient could survive beyond 6 years after AIET, an Ovarian cancer patients could survive more than 2 years after diagnosis of stage IV cancer, and another Ovarian cancer patients beyond 3-years.
Dr. Dedeepiya Devaprasad presented the data of their overall Indian experience which included even advanced inoperable pancreatic cancer patients who could survive beyond 3 years after diagnosis. His talk narrated how this AIET could be further improvised when combined with Monoclonal antibodies.
The Fujio Cup Quiz, an exclusive inter-collegiate national level quiz on stem cells which is conducted for the seventh consecutive time was won by the Chengalpet Medical College team. Handing over the ever rotating Fujio Cup named after the renowned Japanese physician Dr Fujio Takayama to the winners in the valedictory session, the consul general of Japan at Chennai Mr. Masanori Nakano congratulated NCRM for its contribution to this futuristic field of science by conducting this meeting which is the only one of its kind in regenerative medicine in India conducted every year since 2006 and also NCRM being the ONLY Japanese collaborating organization in India in this field. This year being the 60th anniversary of Indo-Japan diplomatic relationship establishment, the NCRM NICHE 2012 had been designated as an official event of the commemoration and The Tamilnadu Dr MGR Medical University had given 10 CME credit points.